세부 사항
산 (RS)- 3 - methyl - 2 - oxovaleric (α-ketoanalogue to DL-isoleucin), muối 칼슘 67,0 mg •
산 4 - methyl - 2 - oxovaleric (α-ketoanalogue to leucin), muối 칼슘 101,0 mg •
산 2 - oxo - 3 - phenylpropionic (α-ketoanalogue to phenylalanin), muối 칼슘 68,0 mg •
산 3 - methyl - 2 - oxobutyric (α-ketoanalogue to valin), muối 칼슘 86,0 mg •
산 (RS)- 2 - hydroxy - 4 - methylthio-butyric (α-hydroxyanalogue to DL-methionin), muối 칼슘 59,0 mg •
L-lysin 아세트산염 (상당 75 mg L-lysin) 105,00 mg •
L-threonin 53,0 mg •
L-tryptophan 23,0 mg •
L-histidin 38,0 mg •
L-tyrosin 30,0 mg 사양
- 제형: 정제 필름코팅
- 포장 단위: 박스 1 백 x 5 블리스터 x 20 정제 필름코팅
- 함량: Acid (RS)-3-methyl-2-oxovaleric (α-ketoanalogue to DL-isoleucin), muối calci 67,0 mg; Acid 4-methyl-2-oxovaleric (α-ketoanalogue to leucin), muối calci 101,0 mg; Acid 2-oxo-3-phenylpropionic (α-ketoanalogue to phenylalanin), muối calci 68,0 mg
- Standards: 자체 규격
- 유통기한: 36 개월
Drug Marketing Authorization Number문서 번호: VN-16263-13
발급일: 2022년 12월 29일
만료일: 2027년 12월 29일
비고: 853/QĐ-QLD | 111
평가 & 댓글 남기기